No Data
No Data
Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025
We're Keeping An Eye On Nautilus Biotechnology's (NASDAQ:NAUT) Cash Burn Rate
Nautilus Biotechnology's CEO Makes a Bold Stock Move!
Insider Purchase: CEO of $NAUT Buys 23,933 Shares
Morgan Stanley Maintains Nautilus Biotechnology(NAUT.US) With Hold Rating, Cuts Target Price to $3
Nautilus Biotechnology: Hold Rating Amid Delayed Launch and Strategic Adjustments